{"id":40206,"date":"2016-07-01T13:12:08","date_gmt":"2016-07-01T18:12:08","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&p=40206"},"modified":"2025-08-29T14:14:42","modified_gmt":"2025-08-29T19:14:42","slug":"cervical-cancer-screening-quality-indicators","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/","title":{"rendered":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016)"},"content":{"rendered":"

Ce rapport se concentre sur les r\u00e9sultats de 12\u00a0mesures du rendement pour les femmes \u00e2g\u00e9es de 21 \u00e0 69\u00a0ans. Afin de fournir des donn\u00e9es de r\u00e9f\u00e9rence et d\u2019examiner le d\u00e9pistage des jeunes femmes au fil des ans, ce rapport comprend \u00e9galement le d\u00e9pistage des femmes de 18 \u00e0 20\u00a0ans. Cela est d\u00fb au fait que les programmes ont modifi\u00e9 l\u2019\u00e2ge de d\u00e9but du d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus \u00e0 21\u00a0ans. Le rapport comprend \u00e9galement de l\u2019information sur les tests de d\u00e9tection du VPH et la vaccination contre le VPH.<\/p>\n

Les programmes de d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus sont de plus en plus organis\u00e9s \u00e0 travers le pays, bien que dans certains territoires de comp\u00e9tence, le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus soit effectu\u00e9 de fa\u00e7on opportuniste par les fournisseurs de soins primaires au lieu des programmes de d\u00e9pistage organis\u00e9. Les programmes offrent des fa\u00e7ons d\u2019all\u00e9ger le fardeau du cancer du col de l\u2019ut\u00e9rus sur le syst\u00e8me de sant\u00e9 et d\u2019\u00e9valuer l\u2019efficacit\u00e9 du d\u00e9pistage.<\/p>\n

Selon les estimations, l\u2019incidence du cancer infiltrant du col de l\u2019ut\u00e9rus est pass\u00e9e de 15,4 \u00e0 7,5 pour 100 000 entre 1977 et 2015<\/p><\/blockquote>\n

La mise en place du d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au moyen du test Pap a men\u00e9 \u00e0 une r\u00e9duction significative de l\u2019incidence de cette maladie et de la mortalit\u00e9 qui y est li\u00e9e au Canada. De 1977 \u00e0 2015, l\u2019incidence du cancer infiltrant du col de l\u2019ut\u00e9rus est pass\u00e9e de 15,4 pour 100\u00a0000 \u00e0 environ 7,5 pour 100\u00a0000. La mortalit\u00e9 li\u00e9e au cancer infiltrant du col de l\u2019ut\u00e9rus est pass\u00e9e de 4,8 pour 100\u00a0000 \u00e0 environ 1,6 pour 100\u00a0000.<\/p>\n

Il est essentiel de surveiller et d\u2019\u00e9valuer le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus de fa\u00e7on continue pour faire en sorte que les Canadiennes re\u00e7oivent des services de haute qualit\u00e9 en mati\u00e8re de pr\u00e9vention du cancer.<\/p>\n

Documents \u00e0 t\u00e9l\u00e9charger<\/strong><\/p>\n

\n <\/i>\n
\n D\u00e9pistage du cancer du\ncol de l\u2019ut\u00e9rus au Canada :\nSURVEILLANCE ET \u00c9VALUATION DES INDICATEURS DE QUALIT\u00c9<\/a>

Taille du fichier 2 MB<\/p> <\/div>\n <\/div><\/div>\n

\n <\/i>\n
\n D\u00e9pistage du cancer du col de l'ut\u00e9rus au Canada : ce que les fournisseurs de soins primaires doivent savoir<\/a>

Taille du fichier 863 KB<\/p> <\/div>\n <\/div><\/div>\n

\n <\/i>\n
\n D\u00e9pistage du cancer du col de l'ut\u00e9rus au Canada : r\u00e9sume du rapport<\/a>

Taille du fichier 827 KB<\/p> <\/div>\n <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

Ce rapport se concentre sur les r\u00e9sultats de 12\u00a0mesures du rendement pour les femmes \u00e2g\u00e9es de 21 \u00e0 69\u00a0ans. Afin de fournir des donn\u00e9es de r\u00e9f\u00e9rence et d\u2019examiner le d\u00e9pistage des jeunes femmes au fil des ans, ce rapport comprend \u00e9galement le d\u00e9pistage des femmes de 18 \u00e0 20\u00a0ans. Cela est d\u00fb au fait que […]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[1647,1648],"cancer-system-measurement":[],"dbt-cancer-site":[474,480],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-40206","topics","type-topics","status-publish","hentry","cancer-continuum-screening-fr","cancer-continuum-diagnosis-fr","dbt-cancer-site-dbv-cervical-fr","dbt-cancer-site-dbv-gynecology-fr"],"acf":[],"yoast_head":"\nCanadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016) - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Ce rapport se concentre sur les r\u00e9sultats de 12\u00a0mesures du rendement pour les femmes \u00e2g\u00e9es de 21 \u00e0 69\u00a0ans. Afin de fournir des donn\u00e9es de r\u00e9f\u00e9rence et d\u2019examiner le d\u00e9pistage des jeunes femmes au fil des ans, ce rapport comprend \u00e9galement le d\u00e9pistage des femmes de 18 \u00e0 20\u00a0ans. Cela est d\u00fb au fait que […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-29T19:14:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/cervical-cancer-screening-quality-indicators\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/cervical-cancer-screening-quality-indicators\\\/\",\"name\":\"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016) - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2016-07-01T18:12:08+00:00\",\"dateModified\":\"2025-08-29T19:14:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/cervical-cancer-screening-quality-indicators\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/cervical-cancer-screening-quality-indicators\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/cervical-cancer-screening-quality-indicators\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016) - Canadian Partnership Against Cancer","og_description":"Ce rapport se concentre sur les r\u00e9sultats de 12\u00a0mesures du rendement pour les femmes \u00e2g\u00e9es de 21 \u00e0 69\u00a0ans. Afin de fournir des donn\u00e9es de r\u00e9f\u00e9rence et d\u2019examiner le d\u00e9pistage des jeunes femmes au fil des ans, ce rapport comprend \u00e9galement le d\u00e9pistage des femmes de 18 \u00e0 20\u00a0ans. Cela est d\u00fb au fait que […]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-08-29T19:14:42+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/","name":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016) - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2016-07-01T18:12:08+00:00","dateModified":"2025-08-29T19:14:42+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/cervical-cancer-screening-quality-indicators\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus au Canada : surveillance et \u00e9valuation des indicateurs de qualit\u00e9 \u2013 rapport des r\u00e9sultats de 2011 \u00e0 2013 (2016)"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/40206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=40206"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=40206"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=40206"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=40206"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=40206"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=40206"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=40206"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=40206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}